| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.38 | 0.03 |